Many insurance companies still classify weight-loss medications as lifestyle treatments rather than medical necessities, despite growing evidence of their benefits for long-term health
The drugs have been credited with reshaping not only individual health but also corporate strategies, food industry investments, and public health discussions about obesity as a chronic disease requiring medical treatment
Amgen also announced it is scrapping plans for an obesity pill, another area of the market that will be competitive, as Lilly, Novo, and Pfizer (PFE) are all working on options
We do not ask that about blood pressure medications or cholesterol medications
There was a high prevalence of cognitive impairment (54.5% and 36.4%, respectively)
The biggest difference lies in caffeine concentration and serving size rather than their overall health effects